Black Rock Inc. Sarepta Therapeutics, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
492Shares Held
89.8MCall Options Held
1.39MPut Options Held
1.11M-
Capital International Investors Los Angeles, CA9.06MShares$108 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$108 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$48.5 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$40.1 Million0.12% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.67MShares$31.9 Million2.76% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.04B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...